NEW YORK, Nov. 7 — Celera Genomics and Compaq Canada have struck a deal designed to increase access to—and cut by nearly half the price of—Celera’s bioinformatics platform for nonprofit research groups in Canada, the companies said on Wednesday.

The agreement combines the purchasing power of the entire Canadian nonprofit research community into one contract, making Celera’s platform technology much cheaper and easier to access, said John Lewis, Celera’s director of academic sales. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.